SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending ahead of its upcoming earnings report as investors debate whether the company's massive hiring and capacity expansion signal a major upside or if governance concerns and margin pressures will persist. The community remains deeply divided, with bulls pointing to the company's critical role in AI infrastructure and its current valuation discount, while bears highlight persistent leadership skepticism and historical price volatility.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently a highly contested topic among investors, with community sentiment deeply polarized between those betting on a generational turnaround driven by insider buying and long-term valuation, and others aggressively shorting the stock due to market share losses, brand fatigue, and intense competition. Traders remain focused on the stock's performance near its decade-lows, debating whether the company can successfully navigate its current restructuring and macroeconomic headwinds.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently driving intense debate as investors weigh record-breaking revenue growth against persistent concerns over its high valuation. While many in the community are celebrating the strong earnings beat and accelerating AI demand, others are skeptical, with active discussions focusing on potential market manipulation and the sustainability of the stock's premium multiple.

Daddy Darth Vader

DARTH CRYPTO is trending as a community-driven alternative in the 'Daddy Wars' meme sector, fueled by excitement for May the Fourth and social media campaigns urging users to rotate their positions into the coin. Community members are actively debating the token's potential as a successor to other prominent meme projects, with significant focus on the absence of a centralized developer and the promise of a community-led rally.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending following a legislative compromise on the Clarity Act that preserves stablecoin reward programs, boosting investor sentiment around its role in digital-asset infrastructure. The community is actively discussing the stock's potential as a long-term play in financial payment rails while debating its price action amid ongoing regulatory and earnings-related speculation.

SKK Holdings Ltd. operates as a holding company, which engages in the provision of civil engineering services in subsurface utility works, including power and telecommunication cable laying, water pipeline and sewer rehabilitation works. The company was founded by Chun Seong Ng and Koon Kiat Sze on October 16, 2013 and is headquartered in Singapore.

SKK Holdings Ltd. - Ordinary Shares - Class A

SKK Holdings Ltd

SKK Holdings is experiencing extreme volatility driven by a major drone asset acquisition agreement, with the community polarized between those chasing the low-float momentum and those warning of significant dilution risks. Traders are focused on the stock's thin float and the rapid, news-fueled price swings, leading to intense debate regarding its long-term viability versus its potential as a short-term scalp.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors aggressively build positions in AI infrastructure, driven by recent news of its Eigen AI acquisition and high-profile hyperscaler contracts. The community is actively debating the company's long-term potential as a standalone hyperscaler, with many comparing its rapid revenue trajectory and strategic growth to other major players in the AI compute sector.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heightened activity driven by a mix of institutional buying and rumors of strategic foundry partnerships with tech giants, fueling a volatile tug-of-war between bullish sentiment around its potential market leadership and bearish concerns over overextended valuations. The community is actively debating whether these gains represent a sustained structural turnaround or a speculative pump, with many focused on how the stock will perform alongside broader semiconductor sector earnings.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is seeing intense investor debate as the market reacts to cooling bookings growth and a strategic pivot prioritizing user engagement over short-term monetization. While community sentiment is heavily polarized between skeptics citing AI disruption and long-term bulls highlighting the company's strong free cash flow and dominant market position, the stock remains a focal point for those looking for a potential turnaround play.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

Cns Pharmaceuticals is experiencing significant market attention and heightened volatility as retail investors and trading communities track its recent private placement financing, which has sparked intense debate over the company's long-term prospects versus its potential for a short-term squeeze. While momentum traders are actively discussing the stock's low float and aggressive intraday price action, others are expressing strong skepticism, warning of dilution risks and the company's complex history with reverse stock splits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mesoblast (NASDAQ:MESO) Shares Cross Above Fifty Day Moving Average   - Here's Why

Mesoblast (NASDAQ:MESO) Stock Price Crosses Above Fifty Day Moving Average - Here's Why...

Mesoblast (NASDAQ:MESO) Shares Gap Up   - Should You Buy?

Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next...

Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced the acquisition of an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform. This innovation is designed to enhance the precision and effectiveness of Mesoblast's mesenchymal lineage st...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Buys 1,586,890 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the company's stock in a transaction dated Thursday, April 9th. The stock was acquired at an...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 1,586,890 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the firm's stock in a transaction dated Thursday, April 9th. The shares were purchased at an...

Gregory George Acquires 2,324,072 Shares of Mesoblast (NASDAQ:MESO) Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George bought 2,324,072 shares of the business's stock in a transaction on Friday, April 10th. The stock was acquired at an average cost of $1.48 per share, for a total transaction of $3,439,626.56. Following the acquisition, the...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 4,000,000 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George purchased 4,000,000 shares of the business's stock in a transaction on Saturday, April 4th. The stock was purchased at an average cost of $1.42 per share, with a total value of $5,680,000.00. Following the completion of the...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Acquires 1,981,890 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George purchased 1,981,890 shares of the stock in a transaction dated Thursday, April 9th. The shares were purchased at an average price of $8.59 per share, for a total transaction of $17,024,435.10. Following the completion of the...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Acquires 2,324,072 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 2,324,072 shares of Mesoblast stock in a transaction that occurred on Friday, April 10th. The stock was acquired at an average cost of $1.48 per share, with a total value of $3,439,626.56. Following the completion of...

Mesoblast R&D Day: Ryonsel Gains Traction, Back Pain Phase III Nears Finish, New Shots on Goal

Mesoblast (NASDAQ:MESO) used its inaugural R&D Day to highlight the commercial progress of its first FDA-approved product, outline multiple Phase III programs aimed at large-market indications, and discuss next-generation technologies the company says could broaden its platform over the next dec...

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

MESO
Mesoblast limited.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MESO News

MESOMesoblast limited.